Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Indivior UK Limited”

34 pharma patents match "Indivior UK Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 34
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 34 pharmaceutical patents matching "Indivior UK Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

34 results for “Indivior UK Limited” · 30,257 patents in full index Clear search

  1. US 12290596

    Compositions and methods for the treatment of opioid overdose

    Indivior UK Limited · Granted May 6, 2025 · Expires May 1, 2045

    granted

  2. US 11839611

    Buprenorphine dosing regimens

    Indivior UK Limited · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted

  3. US 11712475

    Sustained delivery formulations of risperidone compound

    Indivior UK Limited · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted

  4. US 11135216

    Sublingual and buccal film compositions

    Indivior UK Limited · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  5. US 11110093

    Sustained release small molecule drug formulation

    Indivior UK Limited · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  6. US 11013809

    Sustained delivery formulations of risperidone compound

    Indivior UK Limited · Granted May 25, 2021 · Expires May 20, 2041

    granted

  7. US 11000520

    Buprenorphine dosing regimens

    Indivior UK Limited · Granted May 11, 2021 · Expires May 6, 2041

    granted

  8. US 10654842

    Dopamine D3 receptor antagonist compounds

    Indivior UK Limited · Granted May 19, 2020 · Expires May 14, 2040

    granted

  9. US 10646484

    Methods to treat opioid use disorder

    Indivior UK Limited · Granted May 12, 2020 · Expires May 7, 2040

    granted

  10. US 10592168

    Injectable flowable composition comprising buprenorphine

    Indivior UK Limited · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  11. US 10584135

    Substituted 3,6-diazabicyclo[3.2.0]heptanes

    Indivior UK Limited · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  12. US 10577361

    Dopamine D3 receptor antagonists having a morpholine moiety

    Indivior UK Limited · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

  13. US 10558394

    Injectable flowable composition comprising buprenorphine

    Indivior UK Limited · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  14. US 10517864

    Sustained-release buprenorphine solutions

    Indivior UK Limited · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  15. US 10406160

    Sustained release small molecule drug formulation

    Indivior UK Limited · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  16. US 10376590

    Sustained delivery formulations of risperidone compound

    Indivior UK Limited · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  17. US 10273244

    Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulators

    Indivior UK Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  18. US 10239870

    Dopamine D3 receptor antagonists

    Indivior UK Limited · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  19. US 10198218

    Injectable flowable composition comprising buprenorphine

    Indivior UK Limited · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  20. US 10172849

    Compositions comprising buprenorphine

    Indivior UK Limited · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  21. US 10149912

    Dehydrated hydrogel inclusion complex

    Indivior UK Limited · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  22. US 10058554

    Sustained release small molecule drug formulation

    Indivior UK Limited · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  23. US 10022367

    Sustained-release buprenorphine solutions

    Indivior UK Limited · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  24. US 10010612

    Sustained delivery formulations of risperidone compounds

    Indivior UK Limited · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.